EUVIMEDEUVIMED entdecken
Crossref

The Development of Immunological Quantification Method for Glycyrrhetinic Acid in Serum to Estimate the Potential Risk for Pseudoaldsteronism

Shinsuke Hisaka, Yukina Ohno, Kazuko Takeda, Kyonosuke Takahashi, Mao Yano, Hayato Kishi, Sachiko Murase, Mitsuhiko Nose

Planta Medica · 01.08.2026 · 92 (10) · 963-968

DOI: 10.1055/a-2802-8067 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Planta Medica, erschienen am 01.08.2026. Verfasst von Shinsuke Hisaka und 7 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Pharmacy, Meijo University, Aichi, Japan. Hauptthemen laut MEDLINE: Glycyrrhetinic Acid, Liddle Syndrome, Glycyrrhiza.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

AbstractGlycyrrhizae Radix (GR), the dried root and stolon of Glycyrrhiza uralensis or G. glabra, is most frequently used as a crude drug, compounding Kampo medicines to treat a variety of diseases in Japan. This key crude drug, however, would be coinstantaneously a risk factor for pseudoaldosteronism. This adverse effect is thought to be due to glycyrrhetinic acid (GA), a major metabolite of glycyrrhizin, which is one of the ingredients of GR. Therefore, we thought that if the blood GA concentration could be measured quickly and easily when side effects occur, the causal relationship could be clarified, and side effects could be avoided. To realize this plan, we developed the competitive ELISA using anti-GA monoclonal antibody (mAb6D6), which was labeled ʼbiotinʼ to avoid endogenous effects, such as antibodies in serum, and to detect GA sensitively. This ELISA could quantify GA from about 10 pg/mL to 25 ng/mL. The quantitative value of GA in serum based on this ELISA was significantly corelated with that of GA based on high-performance liquid chromatography. Hence, the developed competitive ELISA could be an useful tool for users who would like to quantify the blood GA concentration to clarify the relationship between GA and pseudoaldosteronism derived from the intake of medicines containing GR and to lead to avoiding side effects derived from GA.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Glycyrrhetinic AcidLiddle SyndromeGlycyrrhizaEnzyme-Linked Immunosorbent AssayHumansAntibodies, MonoclonalAnimalsGlycyrrhizic AcidMedicine, Kampo

Substanzen

Glycyrrhetinic AcidAntibodies, MonoclonalGlycyrrhizic Acid

Autor:innen und Institutionen

  • Faculty of Pharmacy, Meijo University, Aichi, Japan.

Zitieren

APA

Hisaka, S., Ohno, Y., Takeda, K., Takahashi, K., Yano, M., Kishi, H., Murase, S., & Nose, M. (2026). The Development of Immunological Quantification Method for Glycyrrhetinic Acid in Serum to Estimate the Potential Risk for Pseudoaldsteronism. Planta Medica, 92(10), 963-968. https://doi.org/10.1055/a-2802-8067

Vancouver

Hisaka S, Ohno Y, Takeda K, Takahashi K, Yano M, Kishi H, et al. The Development of Immunological Quantification Method for Glycyrrhetinic Acid in Serum to Estimate the Potential Risk for Pseudoaldsteronism. Planta Medica. 2026;92(10):963-968. doi:10.1055/a-2802-8067

BibTeX
@article{Hisaka2026,
  author = {Hisaka, Shinsuke and Ohno, Yukina and Takeda, Kazuko and Takahashi, Kyonosuke and Yano, Mao and Kishi, Hayato and Murase, Sachiko and Nose, Mitsuhiko},
  title = {The Development of Immunological Quantification Method for Glycyrrhetinic Acid in Serum to Estimate the Potential Risk for Pseudoaldsteronism},
  journal = {Planta Medica},
  year = {2026},
  volume = {92},
  number = {10},
  pages = {963--968},
  doi = {10.1055/a-2802-8067}
}
Kostenlos starten →